Split History
LPTN split history picture
LPTN (LPTN) has 1 split in our LPTN split history database. The split for LPTN took place on June 13, 2016. This was a 1 for 14 reverse split, meaning for each 14 shares of LPTN owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 71.4285714285714 share position following the split.

When a company such as LPTN conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the LPTN split history from start to finish, an original position size of 1000 shares would have turned into 71.4285714285714 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into LPTN shares, starting with a $10,000 purchase of LPTN, presented on a split-history-adjusted basis factoring in the complete LPTN split history. LPTN split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 06/04/2010
End date: 12/29/2016
Start price/share: $8.40
End price/share: $2.93
Dividends collected/share: $0.00
Total return: -65.12%
Average Annual Total Return: -14.80%
Starting investment: $10,000.00
Ending investment: $3,488.32
Years: 6.58
Apollo Endosurgery is a biotechnology company focused on the discovery and development of lipidomic-based therapeutics antibodies, a field of medical science that targets bioactive signaling lipids to treat a range of human diseases. Co. has developed three product candidates: Lpathomab, which is a humanized monoclonal antibody (mAb) against lysophosphatidic acid for neuropathic pain, chemo-induced pain, traumatic brain injury, and fibrosis; iSONEP™, which is the ocular formulation of sonepcizumab, a mAb against sphingosine-1-phosphate for age-related macular degeneration, RPE detachment, and other retinal diseases; and ASONEP™, which is the systemic formulation of sonepcizumab for cancer. According to our LPTN split history records, LPTN has had 1 split.
Date Ratio
06/13/20161 for 14
LPTN is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

LUX Split History
LXRX Split History
MACK Split History
MBOT Split History
MBVX Split History
MCK Split History
MD Split History
MDCI Split History
MDGL Split History
MDGN Split History

The Cushing NextGen Infrastructure Income Fund (SZC)
Teligent, Inc. (TLGT)
Laredo Petroleum, Inc. (LPI)
Global Eagle Entertainment Inc. (ENT)
ToughBuilt Industries, Inc. (TBLT)
Cyclacel Pharmaceuticals, Inc. (CYCC)
Chesapeake Energy Corporation (CHK)
Direxion Daily Gold Miners Index Bull 3X Shares (NUGT)
Direxion Zacks MLP High Income Index Shares (ZMLP)
Direxion Daily Retail Bull 3X Shares (RETL)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

LPTN Insider Buying

LPTN Split History | www.SplitHistory.com | Copyright © 2013 - 2020, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.